[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-345300-105":59,"doc-detail-345300-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","emerging-roles-for-snrpb2-in-governing-the-cell-cycle-and-steering-tumor-immune-modulation-in-breast-cancer","Emerging roles for SNRPB2 in governing the cell cycle and steering tumor immune modulation in breast cancer","","Breast cancer remains a common malignant disease with limited options and poor prognosis, motivating identification of new molecular targets. This study investigates SNRPB2, a spliceosomal core component regulating pre-mRNA splicing, and examines its contribution to cancer biology and tumor immune microenvironment modulation. Using TCGA, CPTAC, and HPA expression resources plus prognostic Kaplan–Meier analysis, the work tests SNRPB2 function with cell assays, RNA-seq, RT-qPCR, and GEO datasets. Results show SNRPB2 overexpression linked to aggressive progression, G2/M arrest, widespread splicing changes, reduced cell-cycle and immune-regulatory genes, and immune-infiltration patterns associated with immunosuppression.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/emerging-roles-for-snrpb2-in-governing-the-cell-cycle-and-steering-tumor-immune-modulation-in-breast-cancer/345300/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/emerging-roles-for-snrpb2-in-governing-the-cell-cycle-and-steering-tumor-immune-modulation-in-breast-cancer/345300.png","ImageObject",300,407,{"name":92,"@type":93},"Oliver","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":19},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is SNRPB2 and why is it relevant to breast cancer?","Question",{"text":112,"@type":113},"SNRPB2 is a spliceosomal component involved in pre-mRNA splicing. Prior evidence links it to cancer development and immune marker relationships, but its functions in breast cancer were not fully clarified.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was SNRPB2 assessed in breast cancer and what clinical relevance was found?",{"text":117,"@type":113},"SNRPB2 expression was analyzed using TCGA, CPTAC, and HPA databases, with prognostic significance evaluated using Kaplan–Meier plotter. The findings indicate SNRPB2 is overexpressed and associated with malignant progression and poor prognosis.",{"name":119,"@type":110,"acceptedAnswer":120},"What biological effects occur when SNRPB2 is knocked down?",{"text":121,"@type":113},"SNRPB2 knockdown causes G2/M cell cycle arrest and decreases expression of genes related to cell cycle and immune modulation. It also triggers alternative splicing changes across multiple events and implicates HMGA2 splicing and immune-regulatory gene suppression.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},345300,1791086469,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":19,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Molecular Biology Reports (2026) 53:705  \n[https://doi.org/10.1007/s1](https://doi.org/10.1007/s1) 1033-026-11874-z  \nORIGINAL ARTICLE  \nEmerging roles for SNRPB2 in governing the cell cycle and steering tumor immune modulation in breast cancer  \nJiazhennan Zhang1 · Hu Wang2 · Yizhen Jia3 · Adalaiti Yasheng1 · Xiaoye Ai1 · Xiuli Wang1  \nReceived: 9 March 2026 / Accepted: 22 April 2026 © The Author(s) 2026  \nAbstract  \nBackground Breast cancer is a common malignant tumor with limited treatment options and poor prognosis. SNRPB2, a core spliceosomal component involved in pre-mRNA splicing, is dysregulated in multiple cancers, but its role in breast cancer remains incompletely understood.  \nMethods and Results We analyzed SNRPB2 expression in breast cancer using TCGA, CPTAC, and HPA databases, and assessed its prognostic value via Kaplan-Meier plotter. The biological function of SNRPB2 was evaluated through in vitro cell line assay, and the underlying molecular mechanisms were determined via RNA-seq, RT-qPCR, and additional GEO datasets. Our findings demonstrated that SNRPB2 was significantly overexpressed in breast cancer tissues and correlated with malignant progression and poor prognosis. Knockdown of SNRPB2 induced G2/M cell cycle arrest in cancer cells, decreased expression of numerous genes related to cell cycle and immune modulation, and triggered alterations in multiple alternative splicing events. Mechanistically, SNRPB2 knockdown might promote cancer cell cycle arrest by regulating HMGA2 splicing and expression, while simultaneously suppressing the expression of immune-related genes such as CSF1, CSF1R, IL6, and CX3CL1 . Immune infiltration analysis revealed that SNRPB2 expression correlated with increased infiltration of activated inflammatory cells and myeloid-derived suppressor cells.  \nConclusions SNRPB2 potentially plays a dual role in promoting breast cancer progression and shaping the immunosuppressive microenvironment, partly through HMGA2 splicing modulation and immune-regulatory gene suppression. These findings suggest that SNRPB2 may represent a promising therapeutic target for breast cancer.  \nKeywords SNRPB2 · Breast cancer · Transcriptomics · Cell cycle · Immunomodulatory  \nIntroduction  \nBreast cancer is one of the most common female malignant tumors worldwide, with the highest incidence rate of all female malignant tumors, posing a great threat to women’s life and health [1, 2]. Based on molecular typing, breast cancer is subdivided into luminal, HER2 positive, and basal-like types, of which the basal-like type is mostly triple-negative  \n􀀍 Xiuli Wang [110362157@qq.com](110362157@qq.com)  \n1 Phase I Clinical Trial Unit, Xinjiang Medical University Affiliated Tumor Hospital, Urumqi 830011, Xinjiang, China  \n2 Department of Breast Surgery, Xinjiang Medical University Affiliated Tumor Hospital, Urumqi 830011, Xinjiang, China  \n3 Xinjiang Medical University School of Basic Medical Sciences, Urumqi 830011, Xinjiang, China  \nbreast cancer (TNBC) [3]. It is generally recognized that the different subtypes of breast cancer are important prognostic factors, and although this is not absolute, TNBC shows a higher metastatic potential and the most worrying prognosis compared to other subtypes [4] . In recent years, many new treatment regimens have emerged, benefiting the majority of patients; nevertheless, overall outcomes remain far from ideal [5–7]. Therefore, in-depth investigation of the molecular mechanisms underlying breast cancer development and active search for novel therapeutic targets are of great significance for improving patient prognosis.  \nIncreasing evidence indicates that breast cancer pathogenesis results from interactions between tumor cells and the tumor immune microenvironment (TIME) [8] . Cancer cells interact with tumor-infiltrating immune cells within the TIME by expressing cell surface inhibitory ligands/ receptors or by directly secreting cytokines, chemokines, and metabolic substances, wh","cbCaiiYLmElyS95U","https://ap.wps.com/l/cbCaiiYLmElyS95U","pdf",7959885,12,"English","# Abstract\n# Introduction\n# Materials and methods","[{\"question\":\"What is SNRPB2 and why is it relevant to breast cancer?\",\"answer\":\"SNRPB2 is a spliceosomal component involved in pre-mRNA splicing. Prior evidence links it to cancer development and immune marker relationships, but its functions in breast cancer were not fully clarified.\"},{\"question\":\"How was SNRPB2 assessed in breast cancer and what clinical relevance was found?\",\"answer\":\"SNRPB2 expression was analyzed using TCGA, CPTAC, and HPA databases, with prognostic significance evaluated using Kaplan–Meier plotter. The findings indicate SNRPB2 is overexpressed and associated with malignant progression and poor prognosis.\"},{\"question\":\"What biological effects occur when SNRPB2 is knocked down?\",\"answer\":\"SNRPB2 knockdown causes G2/M cell cycle arrest and decreases expression of genes related to cell cycle and immune modulation. It also triggers alternative splicing changes across multiple events and implicates HMGA2 splicing and immune-regulatory gene suppression.\"}]","Emerging roles for SNRPB2 in governing the cell cycle and steering tumor immune modulation in breast cancer | PDF",1790057190,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ff962d7c158ee27c78a386faf99d0414.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3b899a7799c17738027d838c23aaaa8d.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7ce01655e42111af0b759afe9ecc8acf.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/04c9f85edaae392f5f50e6d5280ee0f9.webp",980,1301]